AUTHOR=Tang A-ling , Peng Yu , Shen Mei-jia , Liu Xiao-yu , Li Shan , Xiong Meng-chen , Gao Nan , Hu Tian-peng , Zhang Guo-qiang 

TITLE=Prognostic role of elevated VEGF in sepsis: A systematic review and meta-analysis

JOURNAL=Frontiers in Physiology

VOLUME=13

YEAR=2022

URL=https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2022.941257

DOI=10.3389/fphys.2022.941257

ISSN=1664-042X

ABSTRACT=<p><bold>Background:</bold> The incidence and mortality of sepsis are increasing year by year, and there is still a lack of specific biomarkers to predict its prognosis. Prognostic value of vascular endothelial growth factor (VEGF) in predicting the severity and mortality of sepsis has been gradually discovered.</p><p><bold>Methods:</bold> Literature was searched through Embase, PubMed, Web of Science, China National Knowledge Infrastructure(CNKI) and Cochrane Library databases in March 2022. Observational studies, evaluating the impact of VEGF in sepsis outcomes (mortality and severity) are included in this meta-analysis. Risk of bias was assessed with the Newcastle-Ottawa Scale (NOS). Sensitivity and publication bias analyses were also assessed. Meta-regression analysis were performed to identify the potential sources of heterogeneity.</p><p><bold>Result:</bold> A total of 1,574 articles were retrieved from the systematic literature search. We included 20 studies for qualitative and quantitative analysis. Deceased and critically ill patients had higher baseline VEGF levels than survivors and non-severe patients. The pooled sensitivity and specificity for VEGF predicts sepsis mortality were 0.79and 0.76, respectively. the area under the SROC curve was 0.83.</p><p><bold>Conclusion:</bold> High VEGF are associated with poor clinical outcomes for patients diagnosed with sepsis. This study was recorded on PROSPERO, under the registration ID: CRD42022323079.</p>